Shares of Abbott Laboratories plunged 10.04% to $108.61 Thursday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index rising 0.55% to 6,913.35 and the ...
Now that the Abbott Freestyle Libre has received FDA clearance, Abbott and Dexcom will be forced into tight competition in the US market. On Dexcom’s third quarter call, CEO Kevin Sayer spent some ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results